comparemela.com

Chuck Kummeth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS

MINNEAPOLIS, Feb. 1, 2024 /PRNewswire/ Bio-Techne Corporation today reported its financial results for the second quarter ended December 31, 2023. Second Quarter FY2024 Highlights Second quarter.

United statesWilson wolfKim keldermanDavid clairChuck kummethMatthewf mcmanusBio techne corporationPrnewswire bio techne corporationExchange commissionInvestor relations corporate developmentCompany protein sciencesChangzhou eminence biotechnology co ltdProtein sciences segmentProtein sciencesCompany diagnosticsTechne corporation

BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE

MINNEAPOLIS, Nov. 27, 2023 /PRNewswire/ Bio-Techne Corporation today announced that Chuck Kummeth, President and Chief Executive Officer, and Kim Kelderman, Chief Operating Officer will present.

David clairChuck kummethKim keldermanProtein sciences segmentBio techne corporationInvestor relations corporate developmentChief executive officerChief operating officerAnnual evercoreInvestor relationsTechne corporationProtein sciencesVice president

Bio-Techne Corporation (NASDAQ:TECH) Q1 2024 Earnings Call Transcript

Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2024.

New yorkUnited statesSouth koreaCharles kummethDaniel ariasDavid clairJim hippelJames hippelWilson wolfg rexChuck kummethKim keldermanPuneet soudaRnascope hippleWilson wolfDan ariasProtein sciences

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS

MINNEAPOLIS, Oct. 31, 2023 /PRNewswire/ Bio-Techne Corporation today reported its financial results for the first quarter ended September 30, 2023. First Quarter FY2024 Highlights First quarter.

United statesChuck kummethDavid clairKim keldermanWilson wolfInvestor relations corporate developmentBio techne corporationProtein sciencesProtein sciences segmentCompany diagnosticsPrnewswire bio techne corporationCompany protein sciencesChangzhou eminence biotechnology co ltdExchange commissionTechne corporationGenomics president

Bio-Techne Corp (TECH) Reports 2% Organic Revenue Growth in Q1 FY2024

GAAP Earnings Per Share Drops to $0.31 from $0.55 in the Previous Year

Chuck kummethKim keldermanProtein sciencesBio techne corpGenomics presidentChief executive officerGrowth trajectoriesBio techneArnings per share

vimarsana © 2020. All Rights Reserved.